Cancer BiologybioRxivPreprint
Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activity
Rishi V. Puram, Qiangzong Yin, YuhJong Liu…·Todd R. Golub
This study identifies DNA hypomethylation, not DNA damage, as the primary mechanism of azacytidine and decitabine anti-cancer activity, linking it to chromatin regulators like USP48.
1 citation